Stokes Frank
Chief Financial Officer
Stokes Frank has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Aug 18, 2026.
On the most recent filing, Stokes Frank is listed as Chief Financial Officer at CASTLE BIOSCIENCES INC. Inside the rolling window, Stokes Frank reported no open-market purchases and 5 open-market sales totaling $1.5M in CSTL. The largest disclosed transaction in the window is a sale of 24,908 CSTL shares on Aug 14, 2026, worth $742K.
Companies traded
Other insiders at CSTL
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Stokes Frank made?
Stokes Frank has filed 7 SEC Form 4 filings (15 transaction rows) across 1 company since 2025.
Which companies does Stokes Frank trade?
Stokes Frank has filed SEC Form 4 disclosures for 1 company, including CSTL.
When was Stokes Frank's most recent SEC Form 4 filing?
Stokes Frank's most recent SEC Form 4 filing on Tracefour is dated Aug 18, 2026.
What is Stokes Frank's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Stokes Frank is listed as Chief Financial Officer.
What is Stokes Frank's total buy and sell value in the current window?
Inside the rolling retention window, Stokes Frank bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Stokes Frank's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 24,908 CSTL shares on 2026-08-14, worth $742K, per SEC Form 4 filings.